14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SGYP
Delisted

Synergy Pharmaceuticals Stock Predictions

$0.0064
+0 (+0%)
At Close: Sep 17, 2019
Currently predicting for Mon, 20 May 2024

SGYP Predictions History

6 years ago
JS predicted that SGYP for 2018-01-12 is going $2.43 (1.67%)

6 years ago
bbullish2 predicted that SGYP for 2018-01-12 is going $2.44 (0.83%)

6 years ago
JoeStockTrader predicted that SGYP for 2018-01-02 is going $2.24 (0.45%)

Rank:

7 years ago
lee.stevens.4118 predicted that SGYP for 2017-04-24 is going $4.15 (0.97%)

Rank:

7 years ago
JS predicted that SGYP for 2017-03-27 is going $4.65 (1.75%)

7 years ago
Jack.Cesario.Migueis.3576 predicted that SGYP for 2017-03-27 is going $5.09 (11.38%)

7 years ago
JS predicted that SGYP for 2017-03-06 is going $5.82 (2.11%)

7 years ago
Liam.Siegler.2602 predicted that SGYP for 2017-01-31 is going $6.81 (4.13%)

Rank:

7 years ago
JS predicted that SGYP for 2016-12-23 is going $4.84 (-16.12%)

7 years ago
Nick predicted that SGYP for 2016-08-29 is going $4.80 (2.35%)

Rank:
Click to get the best stock tips daily for free!

About Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333,... SGYP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT